AAAAAA

   
Results: 1-8 |
Results: 8
FDG-PET in adrenocortical carcinoma
Authors: Becherer, A Vierhapper, H Potzi, C Karanikas, G Kurtaran, A Schmaljohann, J Staudenherz, A Dudczak, R Kletter, K
Citation: A. Becherer et al., FDG-PET in adrenocortical carcinoma, CANC BIO R, 16(4), 2001, pp. 289-295
Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr(3)-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy
Authors: Virgolini, I Patri, P Novotny, C Traub, T Leimer, M Fuger, B Li, SR Angelberger, P Raderer, M Wogritsch, S Kurtaran, A Kletter, K Dudczak, R
Citation: I. Virgolini et al., Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr(3)-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy, ANN ONCOL, 12, 2001, pp. S41-S45
Predictive impact of 2-(18)fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma
Authors: De Santis, M Bokemeyer, C Becherer, A Stoiber, F Oechsle, K Kletter, K Dohmen, BM Dittrich, C Pont, J
Citation: M. De Santis et al., Predictive impact of 2-(18)fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma, J CL ONCOL, 19(17), 2001, pp. 3740-3744
FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma
Authors: Zettinig, G Leitha, T Niederle, B Kaserer, K Becherer, A Kletter, K Dudczak, R
Citation: G. Zettinig et al., FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma, CLIN NUCL M, 26(7), 2001, pp. 599-601
F-18-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver
Authors: Kurtaran, A Becherer, A Pfeffel, F Muller, C Traub, T Schmaljohann, J Kaserer, K Raderer, M Schima, W Dudczak, R Kletter, K Virgolini, I
Citation: A. Kurtaran et al., F-18-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver, LIVER, 20(6), 2000, pp. 487-490
Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2
Authors: Bischof, MG Ludwig, C Hofer, A Kletter, K Krebs, M Stingl, H Nowotny, P Waldhausl, W Roden, M
Citation: Mg. Bischof et al., Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2, HORMONE MET, 32(10), 2000, pp. 417-423
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type
Authors: Hoffmann, M Kletter, K Diemling, M Becherer, A Pfeffel, F Petkov, V Chott, A Raderer, M
Citation: M. Hoffmann et al., Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type, ANN ONCOL, 10(10), 1999, pp. 1185-1189
FDG-PET in oncology: techniques and applications
Authors: Kletter, K Becherer, A
Citation: K. Kletter et A. Becherer, FDG-PET in oncology: techniques and applications, RADIOLOGE, 39(7), 1999, pp. 600-609
Risultati: 1-8 |